This webcast features: Milla Neffling, PhD, Bioprocessing Market Segment Manager, 908 Devices. Optimization of feed strategy to boost process productivity and meet critical quality attributes can greatly benefit from using real-time analytics to gain key insights into the process. Frequent measurements of key nutrients and metabolites in spent media also come with the challenge of generating daunting amounts of data. Bioprocess data visualization can therefore be a cumbersome and lengthy task when multiple dynamic key factors are considered. We highlight…
Friday, February 24, 2023 Daily Archives
Resilience MA plant slowdown after Sanofi contract ends
Resilience has reduced operations at a former Sanofi plant in Massachusetts, following the ending of its contract to manufacture enzyme replacement therapy, Cerezyme. Contract development manufacturing organization (CDMO) National Resilience has said it is reducing operations at its 310,000 square-foot plant in Allston, Massachusetts, which it acquired from Sanofi in February 2021. Sanofi itself added the facility through the $20.1 billion acquisition of Genzyme in 2011. The decision to reduce operations at the facility comes after the contract to manufacture…
Agilent breaks ground on $725m site in Colorado
Agilent Technologies has started construction to double manufacturing capacity of therapeutic nucleic acids in Frederick, Colorado. According to the research, development, and manufacturing firm, the facility will create over 160 life sciences jobs in the Frederick location. Additionally, the investment will bolster US production for active pharmaceutical ingredients (APIs) that are used to treat a wide range of illnesses, such as cancer, infectious diseases, and cardiovascular diseases. “Agilent has had a growing presence in Colorado for more than 20 years.…